Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review.

Salma Younes, Nadin Younes, Farah Shurrab, Gheyath K Nasrallah
Author Information
  1. Salma Younes: Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  2. Nadin Younes: Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  3. Farah Shurrab: Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar.
  4. Gheyath K Nasrallah: Biomedical Research Center, Member of QU Health, Qatar University, Doha, Qatar. ORCID

Abstract

The current severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak has been rapidly spreading worldwide, causing serious global concern. The role that animal hosts play in disease transmission is still understudied and researchers wish to find suitable animal models for fundamental research and drug discovery. In this systematic review, we aimed to compile and discuss all articles that describe experimental or natural infections with SARS-CoV-2, from the initial discovery of the virus in December 2019 through to October 2020. We systematically searched four databases (Scopus, PubMed, Science Direct and Web of Science). The following data were extracted from the included studies: type of infection (natural or experimental), age, sample numbers, dose, route of inoculation, viral replication, detection method, clinical symptoms and transmission. Fifty-four studies were included, of which 34 were conducted on animal reservoirs (naturally or experimentally infected), and 20 involved models for testing vaccines and therapeutics. Our search revealed that Rousettus aegyptiacus (fruit bats), pangolins, felines, mink, ferrets and rabbits were all susceptible to SARS-CoV-2, while dogs were weakly susceptible and pigs, poultry, and tree shrews were not. In addition, virus replication in mice, mink, hamsters and ferrets resembled subclinical human infection, so these animals might serve as useful models for future studies to evaluate vaccines or antiviral agents and to study host-pathogen interactions. Our review comprehensively summarized current evidence on SARS-CoV-2 infection in animals and their usefulness as models for studying vaccines and antiviral drugs. Our findings may direct future studies for vaccine development, antiviral drugs and therapeutic agents to manage SARS-CoV-2-caused diseases.

Keywords

References

  1. Nature. 2020 Mar;579(7798):270-273 [PMID: 32015507]
  2. Viruses. 2020 May 26;12(6): [PMID: 32466458]
  3. iScience. 2020 Oct 23;23(10):101585 [PMID: 32989429]
  4. Viruses. 2020 Jul 20;12(7): [PMID: 32698441]
  5. Cell Res. 2020 Apr;30(4):343-355 [PMID: 32231345]
  6. Virus Res. 2008 Apr;133(1):20-32 [PMID: 17499378]
  7. Cell. 2020 Nov 12;183(4):1070-1085.e12 [PMID: 33031744]
  8. Infez Med. 2020 Mar 1;28(1):3-5 [PMID: 32009128]
  9. Animal Model Exp Med. 2020 Mar 30;3(1):93-97 [PMID: 32318665]
  10. PLoS Med. 2009 Jul 21;6(7):e1000097 [PMID: 19621072]
  11. Heliyon. 2020 Sep;6(9):e05116 [PMID: 33015402]
  12. J Infect Dis. 2020 Jul 23;222(4):551-555 [PMID: 32444876]
  13. J Med Virol. 2020 Jun;92(6):595-601 [PMID: 32100877]
  14. Nat Immunol. 2021 Jan;22(1):86-98 [PMID: 33235385]
  15. Cell Mol Immunol. 2020 Jun;17(6):621-630 [PMID: 32415260]
  16. Front Vet Sci. 2020 Jun 09;7:379 [PMID: 32582786]
  17. J Infect Dis. 2018 Nov 22;218(suppl_5):S486-S495 [PMID: 30476250]
  18. Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt A):2733-2741 [PMID: 28729086]
  19. Nature. 2020 Oct;586(7831):776-778 [PMID: 32408337]
  20. Nature. 2020 Feb 21;: [PMID: 33608676]
  21. Cell. 2020 Oct 15;183(2):429-441.e16 [PMID: 32941803]
  22. Nat Med. 2020 Apr;26(4):450-452 [PMID: 32284615]
  23. Clin Rheumatol. 2020 Jul;39(7):2055-2062 [PMID: 32277367]
  24. Vet Q. 2020 Dec;40(1):169-182 [PMID: 32393111]
  25. Sci Transl Med. 2020 Jul 1;12(550): [PMID: 32513867]
  26. N Engl J Med. 2020 Aug 6;383(6):592-594 [PMID: 32402157]
  27. J Med Virol. 2020 Apr;92(4):433-440 [PMID: 31967321]
  28. Cell. 2020 Nov 25;183(5):1354-1366.e13 [PMID: 33065030]
  29. Emerg Infect Dis. 2006 Dec;12(12):1834-40 [PMID: 17326933]
  30. Science. 2020 Jul 3;369(6499):77-81 [PMID: 32376603]
  31. Cell. 2020 Aug 6;182(3):744-753.e4 [PMID: 32553273]
  32. Vet Microbiol. 2020 May;244:108693 [PMID: 32402329]
  33. mBio. 2020 May 22;11(3): [PMID: 32444382]
  34. Nat Commun. 2020 Jul 8;11(1):3496 [PMID: 32641684]
  35. Clin Infect Dis. 2020 Dec 3;71(9):2428-2446 [PMID: 32215622]
  36. Nat Rev Microbiol. 2020 Aug;18(8):461-471 [PMID: 32528128]
  37. Cell Host Microbe. 2020 Jul 8;28(1):124-133.e4 [PMID: 32485164]
  38. Emerg Infect Dis. 2004 Feb;10(2):179-84 [PMID: 15030680]
  39. Lancet Microbe. 2020 Sep;1(5):e218-e225 [PMID: 32838346]
  40. Vet Q. 2020 Dec;40(1):68-76 [PMID: 32036774]
  41. J Clin Med. 2020 Feb 11;9(2): [PMID: 32054045]
  42. Cell Rep. 2020 Jun 2;31(9):107725 [PMID: 32426212]
  43. Nat Commun. 2020 Sep 2;11(1):4400 [PMID: 32879306]
  44. Int J Infect Dis. 2020 Sep;98:372-380 [PMID: 32623083]
  45. Euro Surveill. 2020 Jun;25(23): [PMID: 32553059]
  46. Nature. 2020 Jul;583(7818):834-838 [PMID: 32408338]
  47. Sci Transl Med. 2020 Apr 29;12(541): [PMID: 32253226]
  48. Pathog Dis. 2019 Dec 1;77(9): [PMID: 32065221]
  49. Nature. 2020 Jul;583(7815):282-285 [PMID: 32218527]
  50. Science. 2020 Aug 21;369(6506):956-963 [PMID: 32540903]
  51. Curr Biol. 2020 Apr 6;30(7):1346-1351.e2 [PMID: 32197085]
  52. Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595 [PMID: 32571934]
  53. Science. 2020 Jun 12;368(6496):1274-1278 [PMID: 32404477]
  54. Nat Biotechnol. 2020 Nov;38(11):1242-1252 [PMID: 33087898]
  55. Front Microbiol. 2016 Feb 04;7:80 [PMID: 26870031]
  56. Viruses. 2019 Mar 02;11(3): [PMID: 30832341]
  57. Cell. 2020 Aug 6;182(3):713-721.e9 [PMID: 32778225]
  58. Front Microbiol. 2020 Sep 30;11:580137 [PMID: 33101254]
  59. Sci Rep. 2020 Sep 29;10(1):16007 [PMID: 32994418]
  60. Cell Host Microbe. 2020 May 13;27(5):704-709.e2 [PMID: 32259477]
  61. Cell. 2020 Jul 9;182(1):50-58.e8 [PMID: 32516571]
  62. Science. 2020 May 29;368(6494):1012-1015 [PMID: 32303590]
  63. Nature. 2020 Jul;583(7818):830-833 [PMID: 32380511]
  64. Trends Microbiol. 2015 Aug;23(8):468-78 [PMID: 26206723]
  65. Science. 2020 May 29;368(6494):1016-1020 [PMID: 32269068]
  66. Cell. 2020 Aug 6;182(3):734-743.e5 [PMID: 32643603]
  67. Nature. 2020 Oct;586(7830):560-566 [PMID: 32854108]
  68. Nature. 2020 Oct;586(7830):516-527 [PMID: 32967006]
  69. Nat Rev Microbiol. 2019 Mar;17(3):181-192 [PMID: 30531947]
  70. Emerg Microbes Infect. 2021 Dec;10(1):1-7 [PMID: 33356979]
  71. Lancet. 2020 Feb 15;395(10223):497-506 [PMID: 31986264]
  72. Nat Commun. 2020 Nov 17;11(1):5838 [PMID: 33203860]
  73. J Exp Med. 2020 Dec 7;217(12): [PMID: 32750141]
  74. Emerg Infect Dis. 2020 Jul;26(7):1478-1488 [PMID: 32267220]
  75. One Health. 2020 Dec;10:100164 [PMID: 32904469]
  76. Science. 2020 Aug 14;369(6505):806-811 [PMID: 32434945]
  77. Science. 2020 Aug 14;369(6505):812-817 [PMID: 32434946]
  78. Transbound Emerg Dis. 2020 Nov;67(6):2324-2328 [PMID: 32500944]
  79. Curr Opin Virol. 2015 Aug;13:123-9 [PMID: 26184451]
  80. Cell. 2020 May 28;181(5):1036-1045.e9 [PMID: 32416070]
  81. Rev Med Virol. 2021 Jul;31(4):e2196 [PMID: 33206434]
  82. Sci Total Environ. 2021 Jan 1;750:141483 [PMID: 32829257]
  83. Cell Rep. 2020 Jul 21;32(3):107940 [PMID: 32668216]
  84. Int J Infect Dis. 2020 Feb;91:264-266 [PMID: 31953166]
  85. Nature. 2020 Sep;585(7824):268-272 [PMID: 32396922]
  86. Nature. 2020 Sep;585(7824):273-276 [PMID: 32516797]
  87. Nature. 2020 Apr 1;: [PMID: 32238897]
  88. Nature. 2020 Mar;579(7798):265-269 [PMID: 32015508]
  89. Virology. 2015 May;479-480:247-58 [PMID: 25791336]
  90. Euro Surveill. 2020 Mar;25(10): [PMID: 32183930]

Grants

  1. RRC-2-032/Qatar National Research Fund

MeSH Term

Animals
Animals, Domestic
Animals, Wild
COVID-19
Disease Models, Animal
Disease Reservoirs
Disease Susceptibility
Severe acute respiratory syndrome-related coronavirus

Word Cloud

Created with Highcharts 10.0.0animalSARS-CoV-2modelsvaccinesreviewexperimentalnaturalinfectionstudiesantiviralagentscurrentacuterespiratorysyndromecoronavirus-2hoststransmissiondiscoverysystematicvirusScienceincludedreplicationreservoirsminkferretssusceptibleanimalsfuturedrugstherapeuticsevereoutbreakrapidlyspreadingworldwidecausingseriousglobalconcernroleplaydiseasestillunderstudiedresearcherswishfindsuitablefundamentalresearchdrugaimedcompilediscussarticlesdescribeinfectionsinitialDecember2019October2020systematicallysearchedfourdatabasesScopusPubMedDirectWebfollowingdataextractedstudies:typeagesamplenumbersdoserouteinoculationviraldetectionmethodclinicalsymptomsFifty-four34conductednaturallyexperimentallyinfected20involvedtestingtherapeuticssearchrevealedRousettusaegyptiacusfruitbatspangolinsfelinesrabbitsdogsweaklypigspoultrytreeshrewsadditionmicehamstersresembledsubclinicalhumanmightserveusefulevaluatestudyhost-pathogeninteractionscomprehensivelysummarizedevidenceusefulnessstudyingfindingsmaydirectvaccinedevelopmentmanageSARS-CoV-2-causeddiseasesSeveremodels:Covid-19

Similar Articles

Cited By